HEADER SIGNALING PROTEIN 07-JUN-18 6GQK TITLE CRYSTAL STRUCTURE OF HUMAN C-KIT KINASE DOMAIN IN COMPLEX WITH TITLE 2 AZD3229-ANALOGUE (COMPOUND 23) COMPND MOL_ID: 1; COMPND 2 MOLECULE: MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SCFR,PIEBALD TRAIT PROTEIN,PBT,PROTO-ONCOGENE C-KIT, COMPND 5 TYROSINE-PROTEIN KINASE KIT,P145 C-KIT,V-KIT HARDY-ZUCKERMAN 4 FELINE COMPND 6 SARCOMA VIRAL ONCOGENE HOMOLOG,SCFR,PIEBALD TRAIT PROTEIN,PBT,PROTO- COMPND 7 ONCOGENE C-KIT,TYROSINE-PROTEIN KINASE KIT,P145 C-KIT,V-KIT HARDY- COMPND 8 ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG; COMPND 9 EC: 2.7.10.1,2.7.10.1; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES; COMPND 12 OTHER_DETAILS: HUMAN C-KIT KINASE DOMAIN (P551-H934) BEARING SURFACE COMPND 13 MUTATIONS TO OPTIMISE PROTEIN EXPRESSION (I563S, V569S, Y609Q, L631S, COMPND 14 M651E, I662H, D768H, R804N, V825D, C844S, L890S, H894Y, L912D, COMPND 15 L923D), AND THE KINASE INSERT DOMAIN(S688-D765) DELETED AND REPLACED COMPND 16 WITH THE SEQUENCE EFVPYKVAPEDLYKDFLT SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KIT, SCFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: STAR KEYWDS RECEPTOR TYROSINE KINASE, INHIBITOR, ONCOLOGY, GASTROINTESTINAL KEYWDS 2 STROMAL TUMOUR, STRUCTURE-BASED DRUG DESIGN, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.SCHIMPL,C.J.HARDY,D.J.OGG,R.C.OVERMAN,M.J.PACKER,J.G.KETTLE, AUTHOR 2 R.ANJUM,E.BARRY,D.BHAVSAR,C.BROWN,A.CAMPBELL,K.GOLDBERG,M.GRONDINE, AUTHOR 3 S.GUICHARD,T.HUNT,O.JONES,X.LI,O.MOLEVA,S.PEARSON,W.SHAO,A.SMITH, AUTHOR 4 J.SMITH,D.STEAD,S.STOKES,M.TUCKER,Y.YE REVDAT 3 31-OCT-18 6GQK 1 JRNL REVDAT 2 03-OCT-18 6GQK 1 JRNL REVDAT 1 19-SEP-18 6GQK 0 JRNL AUTH J.G.KETTLE,R.ANJUM,E.BARRY,D.BHAVSAR,C.BROWN,S.BOYD, JRNL AUTH 2 A.CAMPBELL,K.GOLDBERG,M.GRONDINE,S.GUICHARD,C.J.HARDY, JRNL AUTH 3 T.HUNT,R.D.O.JONES,X.LI,O.MOLEVA,D.OGG,R.C.OVERMAN, JRNL AUTH 4 M.J.PACKER,S.PEARSON,M.SCHIMPL,W.SHAO,A.SMITH,J.M.SMITH, JRNL AUTH 5 D.STEAD,S.STOKES,M.TUCKER,Y.YE JRNL TITL DISCOVERY OF JRNL TITL 2 N-(4-{[5-FLUORO-7-(2-METHOXYETHOXY) JRNL TITL 3 QUINAZOLIN-4-YL]AMINO}PHENYL)-2-[4-(PROPAN-2-YL)-1 JRNL TITL 4 H-1,2,3-TRIAZOL-1-YL]ACETAMIDE (AZD3229), A POTENT PAN-KIT JRNL TITL 5 MUTANT INHIBITOR FOR THE TREATMENT OF GASTROINTESTINAL JRNL TITL 6 STROMAL TUMORS. JRNL REF J. MED. CHEM. V. 61 8797 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30204441 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00938 REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 64.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 33204 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.250 REMARK 3 FREE R VALUE TEST SET COUNT : 1744 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 17 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.38 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.82 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2826 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2310 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2630 REMARK 3 BIN R VALUE (WORKING SET) : 0.2290 REMARK 3 BIN FREE R VALUE : 0.2600 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.94 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 196 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4770 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 222 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 51.64 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.60900 REMARK 3 B22 (A**2) : -2.20600 REMARK 3 B33 (A**2) : 2.81500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.280 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.279 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.199 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.270 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.198 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4971 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6727 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1711 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 109 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 712 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4971 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 615 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5240 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.97 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.94 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.52 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 27.4957 98.7064 16.5737 REMARK 3 T TENSOR REMARK 3 T11: -0.3345 T22: -0.2446 REMARK 3 T33: -0.2995 T12: -0.0395 REMARK 3 T13: -0.0247 T23: -0.0168 REMARK 3 L TENSOR REMARK 3 L11: 1.1080 L22: 1.6133 REMARK 3 L33: 2.6638 L12: 0.1041 REMARK 3 L13: -0.5713 L23: -0.4604 REMARK 3 S TENSOR REMARK 3 S11: -0.0351 S12: 0.0269 S13: -0.0703 REMARK 3 S21: 0.0175 S22: -0.0140 S23: -0.0194 REMARK 3 S31: 0.0433 S32: 0.0236 S33: 0.0491 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 63.8464 92.3070 20.5672 REMARK 3 T TENSOR REMARK 3 T11: -0.3596 T22: -0.2950 REMARK 3 T33: -0.2738 T12: -0.0579 REMARK 3 T13: -0.0116 T23: 0.0005 REMARK 3 L TENSOR REMARK 3 L11: 1.4454 L22: 4.6456 REMARK 3 L33: 1.3566 L12: -0.5144 REMARK 3 L13: 0.0792 L23: -0.1691 REMARK 3 S TENSOR REMARK 3 S11: -0.0639 S12: 0.0073 S13: 0.2952 REMARK 3 S21: -0.1921 S22: 0.0903 S23: -0.0218 REMARK 3 S31: -0.2125 S32: 0.1116 S33: -0.0264 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6GQK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1200010040. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-NOV-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92819 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33255 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.310 REMARK 200 RESOLUTION RANGE LOW (A) : 64.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.84000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: BAR REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 % PEG 8000, 20 % ETHYLENE GLYCOL, REMARK 280 0.1 M TRIS-BICINE PH 8.5, 0.03 M SODIUM FLUORIDE, 0.03 M SODIUM REMARK 280 BROMIDE, 0.03 M SODIUM IODIDE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 44.09500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.01500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.82500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.01500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 44.09500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.82500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 547 REMARK 465 SER A 548 REMARK 465 HIS A 549 REMARK 465 MET A 550 REMARK 465 PRO A 551 REMARK 465 MET A 552 REMARK 465 TYR A 553 REMARK 465 GLU A 554 REMARK 465 VAL A 555 REMARK 465 GLN A 556 REMARK 465 TRP A 557 REMARK 465 LYS A 558 REMARK 465 VAL A 559 REMARK 465 VAL A 560 REMARK 465 GLU A 561 REMARK 465 GLU A 562 REMARK 465 SER A 563 REMARK 465 ASN A 564 REMARK 465 GLY A 565 REMARK 465 ASN A 566 REMARK 465 THR A 932 REMARK 465 ASN A 933 REMARK 465 HIS A 934 REMARK 465 GLY B 547 REMARK 465 SER B 548 REMARK 465 HIS B 549 REMARK 465 MET B 550 REMARK 465 PRO B 551 REMARK 465 MET B 552 REMARK 465 TYR B 553 REMARK 465 GLU B 554 REMARK 465 VAL B 555 REMARK 465 GLN B 556 REMARK 465 TRP B 557 REMARK 465 LYS B 558 REMARK 465 VAL B 559 REMARK 465 VAL B 560 REMARK 465 GLU B 561 REMARK 465 GLU B 562 REMARK 465 SER B 563 REMARK 465 ASN B 564 REMARK 465 GLY B 565 REMARK 465 ASN B 566 REMARK 465 ASN B 567 REMARK 465 TYR B 568 REMARK 465 SER B 569 REMARK 465 TYR B 570 REMARK 465 ILE B 571 REMARK 465 ALA B 755 REMARK 465 PRO B 756 REMARK 465 GLU B 757 REMARK 465 ASP B 758 REMARK 465 LEU B 759 REMARK 465 TYR B 760 REMARK 465 LYS B 761 REMARK 465 THR B 932 REMARK 465 ASN B 933 REMARK 465 HIS B 934 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 580 3.25 -69.81 REMARK 500 ASP A 615 26.23 -75.08 REMARK 500 TYR A 692 -142.48 -81.80 REMARK 500 ASP A 762 63.30 67.21 REMARK 500 ARG A 791 -11.37 79.41 REMARK 500 ASP A 792 42.86 -143.60 REMARK 500 THR A 801 -161.74 -117.98 REMARK 500 ASP B 615 26.89 -75.42 REMARK 500 HIS B 630 -154.96 -102.31 REMARK 500 ARG B 791 -11.08 79.41 REMARK 500 ASP B 792 43.89 -143.63 REMARK 500 THR B 801 -160.27 -118.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F88 A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F88 B 1001 DBREF 6GQK A 551 687 UNP P10721 KIT_HUMAN 551 687 DBREF 6GQK A 771 934 UNP P10721 KIT_HUMAN 771 934 DBREF 6GQK B 551 687 UNP P10721 KIT_HUMAN 551 687 DBREF 6GQK B 771 934 UNP P10721 KIT_HUMAN 771 934 SEQADV 6GQK GLY A 547 UNP P10721 EXPRESSION TAG SEQADV 6GQK SER A 548 UNP P10721 EXPRESSION TAG SEQADV 6GQK HIS A 549 UNP P10721 EXPRESSION TAG SEQADV 6GQK MET A 550 UNP P10721 EXPRESSION TAG SEQADV 6GQK SER A 563 UNP P10721 ILE 563 ENGINEERED MUTATION SEQADV 6GQK SER A 569 UNP P10721 VAL 569 ENGINEERED MUTATION SEQADV 6GQK GLN A 609 UNP P10721 TYR 609 ENGINEERED MUTATION SEQADV 6GQK SER A 631 UNP P10721 LEU 631 ENGINEERED MUTATION SEQADV 6GQK GLU A 651 UNP P10721 MET 651 ENGINEERED MUTATION SEQADV 6GQK HIS A 662 UNP P10721 ILE 662 ENGINEERED MUTATION SEQADV 6GQK GLU A 688 UNP P10721 LINKER SEQADV 6GQK PHE A 689 UNP P10721 LINKER SEQADV 6GQK VAL A 690 UNP P10721 LINKER SEQADV 6GQK PRO A 691 UNP P10721 LINKER SEQADV 6GQK TYR A 692 UNP P10721 LINKER SEQADV 6GQK LYS A 693 UNP P10721 LINKER SEQADV 6GQK VAL A 694 UNP P10721 LINKER SEQADV 6GQK ALA A 695 UNP P10721 LINKER SEQADV 6GQK PRO A 696 UNP P10721 LINKER SEQADV 6GQK GLU A 757 UNP P10721 LINKER SEQADV 6GQK ASP A 758 UNP P10721 LINKER SEQADV 6GQK LEU A 759 UNP P10721 LINKER SEQADV 6GQK TYR A 760 UNP P10721 LINKER SEQADV 6GQK LYS A 761 UNP P10721 LINKER SEQADV 6GQK ASP A 762 UNP P10721 LINKER SEQADV 6GQK PHE A 763 UNP P10721 LINKER SEQADV 6GQK LEU A 764 UNP P10721 LINKER SEQADV 6GQK THR A 765 UNP P10721 LINKER SEQADV 6GQK LEU A 766 UNP P10721 LINKER SEQADV 6GQK GLU A 767 UNP P10721 LINKER SEQADV 6GQK HIS A 768 UNP P10721 LINKER SEQADV 6GQK LEU A 769 UNP P10721 LINKER SEQADV 6GQK LEU A 770 UNP P10721 LINKER SEQADV 6GQK ASN A 804 UNP P10721 ARG 804 ENGINEERED MUTATION SEQADV 6GQK ASP A 825 UNP P10721 VAL 825 ENGINEERED MUTATION SEQADV 6GQK SER A 844 UNP P10721 CYS 844 ENGINEERED MUTATION SEQADV 6GQK SER A 890 UNP P10721 LEU 890 ENGINEERED MUTATION SEQADV 6GQK TYR A 894 UNP P10721 HIS 894 ENGINEERED MUTATION SEQADV 6GQK ASP A 912 UNP P10721 LEU 912 ENGINEERED MUTATION SEQADV 6GQK ASP A 923 UNP P10721 LEU 923 ENGINEERED MUTATION SEQADV 6GQK GLY B 547 UNP P10721 EXPRESSION TAG SEQADV 6GQK SER B 548 UNP P10721 EXPRESSION TAG SEQADV 6GQK HIS B 549 UNP P10721 EXPRESSION TAG SEQADV 6GQK MET B 550 UNP P10721 EXPRESSION TAG SEQADV 6GQK SER B 563 UNP P10721 ILE 563 ENGINEERED MUTATION SEQADV 6GQK SER B 569 UNP P10721 VAL 569 ENGINEERED MUTATION SEQADV 6GQK GLN B 609 UNP P10721 TYR 609 ENGINEERED MUTATION SEQADV 6GQK SER B 631 UNP P10721 LEU 631 ENGINEERED MUTATION SEQADV 6GQK GLU B 651 UNP P10721 MET 651 ENGINEERED MUTATION SEQADV 6GQK HIS B 662 UNP P10721 ILE 662 ENGINEERED MUTATION SEQADV 6GQK GLU B 688 UNP P10721 LINKER SEQADV 6GQK PHE B 689 UNP P10721 LINKER SEQADV 6GQK VAL B 690 UNP P10721 LINKER SEQADV 6GQK PRO B 691 UNP P10721 LINKER SEQADV 6GQK TYR B 692 UNP P10721 LINKER SEQADV 6GQK LYS B 693 UNP P10721 LINKER SEQADV 6GQK VAL B 694 UNP P10721 LINKER SEQADV 6GQK ALA B 755 UNP P10721 LINKER SEQADV 6GQK PRO B 756 UNP P10721 LINKER SEQADV 6GQK GLU B 757 UNP P10721 LINKER SEQADV 6GQK ASP B 758 UNP P10721 LINKER SEQADV 6GQK LEU B 759 UNP P10721 LINKER SEQADV 6GQK TYR B 760 UNP P10721 LINKER SEQADV 6GQK LYS B 761 UNP P10721 LINKER SEQADV 6GQK ASP B 762 UNP P10721 LINKER SEQADV 6GQK PHE B 763 UNP P10721 LINKER SEQADV 6GQK LEU B 764 UNP P10721 LINKER SEQADV 6GQK THR B 765 UNP P10721 LINKER SEQADV 6GQK LEU B 766 UNP P10721 LINKER SEQADV 6GQK GLU B 767 UNP P10721 LINKER SEQADV 6GQK HIS B 768 UNP P10721 LINKER SEQADV 6GQK LEU B 769 UNP P10721 LINKER SEQADV 6GQK LEU B 770 UNP P10721 LINKER SEQADV 6GQK ASN B 804 UNP P10721 ARG 804 ENGINEERED MUTATION SEQADV 6GQK ASP B 825 UNP P10721 VAL 825 ENGINEERED MUTATION SEQADV 6GQK SER B 844 UNP P10721 CYS 844 ENGINEERED MUTATION SEQADV 6GQK SER B 890 UNP P10721 LEU 890 ENGINEERED MUTATION SEQADV 6GQK TYR B 894 UNP P10721 HIS 894 ENGINEERED MUTATION SEQADV 6GQK ASP B 912 UNP P10721 LEU 912 ENGINEERED MUTATION SEQADV 6GQK ASP B 923 UNP P10721 LEU 923 ENGINEERED MUTATION SEQRES 1 A 328 GLY SER HIS MET PRO MET TYR GLU VAL GLN TRP LYS VAL SEQRES 2 A 328 VAL GLU GLU SER ASN GLY ASN ASN TYR SER TYR ILE ASP SEQRES 3 A 328 PRO THR GLN LEU PRO TYR ASP HIS LYS TRP GLU PHE PRO SEQRES 4 A 328 ARG ASN ARG LEU SER PHE GLY LYS THR LEU GLY ALA GLY SEQRES 5 A 328 ALA PHE GLY LYS VAL VAL GLU ALA THR ALA GLN GLY LEU SEQRES 6 A 328 ILE LYS SER ASP ALA ALA MET THR VAL ALA VAL LYS MET SEQRES 7 A 328 LEU LYS PRO SER ALA HIS SER THR GLU ARG GLU ALA LEU SEQRES 8 A 328 MET SER GLU LEU LYS VAL LEU SER TYR LEU GLY ASN HIS SEQRES 9 A 328 GLU ASN ILE VAL ASN LEU LEU GLY ALA CYS THR HIS GLY SEQRES 10 A 328 GLY PRO THR LEU VAL ILE THR GLU TYR CYS CYS TYR GLY SEQRES 11 A 328 ASP LEU LEU ASN PHE LEU ARG ARG LYS ARG ASP GLU PHE SEQRES 12 A 328 VAL PRO TYR LYS VAL ALA PRO GLU ASP LEU TYR LYS ASP SEQRES 13 A 328 PHE LEU THR LEU GLU HIS LEU LEU SER PHE SER TYR GLN SEQRES 14 A 328 VAL ALA LYS GLY MET ALA PHE LEU ALA SER LYS ASN CYS SEQRES 15 A 328 ILE HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU LEU THR SEQRES 16 A 328 HIS GLY ASN ILE THR LYS ILE CYS ASP PHE GLY LEU ALA SEQRES 17 A 328 ARG ASP ILE LYS ASN ASP SER ASN TYR VAL ASP LYS GLY SEQRES 18 A 328 ASN ALA ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SER SEQRES 19 A 328 ILE PHE ASN SER VAL TYR THR PHE GLU SER ASP VAL TRP SEQRES 20 A 328 SER TYR GLY ILE PHE LEU TRP GLU LEU PHE SER LEU GLY SEQRES 21 A 328 SER SER PRO TYR PRO GLY MET PRO VAL ASP SER LYS PHE SEQRES 22 A 328 TYR LYS MET ILE LYS GLU GLY PHE ARG MET SER SER PRO SEQRES 23 A 328 GLU TYR ALA PRO ALA GLU MET TYR ASP ILE MET LYS THR SEQRES 24 A 328 CYS TRP ASP ALA ASP PRO ASP LYS ARG PRO THR PHE LYS SEQRES 25 A 328 GLN ILE VAL GLN ASP ILE GLU LYS GLN ILE SER GLU SER SEQRES 26 A 328 THR ASN HIS SEQRES 1 B 328 GLY SER HIS MET PRO MET TYR GLU VAL GLN TRP LYS VAL SEQRES 2 B 328 VAL GLU GLU SER ASN GLY ASN ASN TYR SER TYR ILE ASP SEQRES 3 B 328 PRO THR GLN LEU PRO TYR ASP HIS LYS TRP GLU PHE PRO SEQRES 4 B 328 ARG ASN ARG LEU SER PHE GLY LYS THR LEU GLY ALA GLY SEQRES 5 B 328 ALA PHE GLY LYS VAL VAL GLU ALA THR ALA GLN GLY LEU SEQRES 6 B 328 ILE LYS SER ASP ALA ALA MET THR VAL ALA VAL LYS MET SEQRES 7 B 328 LEU LYS PRO SER ALA HIS SER THR GLU ARG GLU ALA LEU SEQRES 8 B 328 MET SER GLU LEU LYS VAL LEU SER TYR LEU GLY ASN HIS SEQRES 9 B 328 GLU ASN ILE VAL ASN LEU LEU GLY ALA CYS THR HIS GLY SEQRES 10 B 328 GLY PRO THR LEU VAL ILE THR GLU TYR CYS CYS TYR GLY SEQRES 11 B 328 ASP LEU LEU ASN PHE LEU ARG ARG LYS ARG ASP GLU PHE SEQRES 12 B 328 VAL PRO TYR LYS VAL ALA PRO GLU ASP LEU TYR LYS ASP SEQRES 13 B 328 PHE LEU THR LEU GLU HIS LEU LEU SER PHE SER TYR GLN SEQRES 14 B 328 VAL ALA LYS GLY MET ALA PHE LEU ALA SER LYS ASN CYS SEQRES 15 B 328 ILE HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU LEU THR SEQRES 16 B 328 HIS GLY ASN ILE THR LYS ILE CYS ASP PHE GLY LEU ALA SEQRES 17 B 328 ARG ASP ILE LYS ASN ASP SER ASN TYR VAL ASP LYS GLY SEQRES 18 B 328 ASN ALA ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SER SEQRES 19 B 328 ILE PHE ASN SER VAL TYR THR PHE GLU SER ASP VAL TRP SEQRES 20 B 328 SER TYR GLY ILE PHE LEU TRP GLU LEU PHE SER LEU GLY SEQRES 21 B 328 SER SER PRO TYR PRO GLY MET PRO VAL ASP SER LYS PHE SEQRES 22 B 328 TYR LYS MET ILE LYS GLU GLY PHE ARG MET SER SER PRO SEQRES 23 B 328 GLU TYR ALA PRO ALA GLU MET TYR ASP ILE MET LYS THR SEQRES 24 B 328 CYS TRP ASP ALA ASP PRO ASP LYS ARG PRO THR PHE LYS SEQRES 25 B 328 GLN ILE VAL GLN ASP ILE GLU LYS GLN ILE SER GLU SER SEQRES 26 B 328 THR ASN HIS HET F88 A1001 32 HET F88 B1001 32 HETNAM F88 ~{N}-[4-(6,7-DIMETHOXYQUINAZOLIN-4-YL)OXYPHENYL]-2-(1- HETNAM 2 F88 ETHYLPYRAZOL-4-YL)ETHANAMIDE FORMUL 3 F88 2(C23 H23 N5 O4) FORMUL 5 HOH *222(H2 O) HELIX 1 AA1 ASP A 572 LEU A 576 5 5 HELIX 2 AA2 ASP A 579 GLU A 583 5 5 HELIX 3 AA3 PRO A 585 ASN A 587 5 3 HELIX 4 AA4 HIS A 630 GLY A 648 1 19 HELIX 5 AA5 ASP A 677 ARG A 686 1 10 HELIX 6 AA6 GLU A 757 ASP A 762 5 6 HELIX 7 AA7 LEU A 766 LYS A 786 1 21 HELIX 8 AA8 ALA A 794 ARG A 796 5 3 HELIX 9 AA9 HIS A 802 ASN A 804 5 3 HELIX 10 AB1 PHE A 811 ARG A 815 5 5 HELIX 11 AB2 PRO A 832 MET A 836 5 5 HELIX 12 AB3 ALA A 837 SER A 844 1 8 HELIX 13 AB4 THR A 847 SER A 864 1 18 HELIX 14 AB5 ASP A 876 GLU A 885 1 10 HELIX 15 AB6 PRO A 896 TRP A 907 1 12 HELIX 16 AB7 ASP A 910 ARG A 914 5 5 HELIX 17 AB8 THR A 916 SER A 931 1 16 HELIX 18 AB9 ASP B 572 LEU B 576 5 5 HELIX 19 AC1 ASP B 579 GLU B 583 5 5 HELIX 20 AC2 PRO B 585 ASN B 587 5 3 HELIX 21 AC3 HIS B 630 GLY B 648 1 19 HELIX 22 AC4 ASP B 677 ARG B 686 1 10 HELIX 23 AC5 ASP B 687 PHE B 689 5 3 HELIX 24 AC6 THR B 765 LYS B 786 1 22 HELIX 25 AC7 ALA B 794 ARG B 796 5 3 HELIX 26 AC8 HIS B 802 ASN B 804 5 3 HELIX 27 AC9 PHE B 811 ARG B 815 5 5 HELIX 28 AD1 ASP B 816 ASP B 820 5 5 HELIX 29 AD2 PRO B 832 MET B 836 5 5 HELIX 30 AD3 ALA B 837 SER B 844 1 8 HELIX 31 AD4 THR B 847 SER B 864 1 18 HELIX 32 AD5 ASP B 876 GLU B 885 1 10 HELIX 33 AD6 PRO B 896 TRP B 907 1 12 HELIX 34 AD7 ASP B 910 ARG B 914 5 5 HELIX 35 AD8 THR B 916 SER B 931 1 16 SHEET 1 AA1 5 LEU A 589 ALA A 597 0 SHEET 2 AA1 5 GLY A 601 ALA A 608 -1 O GLU A 605 N GLY A 592 SHEET 3 AA1 5 MET A 618 LEU A 625 -1 O MET A 618 N ALA A 608 SHEET 4 AA1 5 LEU A 667 GLU A 671 -1 O VAL A 668 N LYS A 623 SHEET 5 AA1 5 LEU A 656 CYS A 660 -1 N LEU A 657 O ILE A 669 SHEET 1 AA2 2 PHE A 689 VAL A 690 0 SHEET 2 AA2 2 LEU A 764 THR A 765 1 O LEU A 764 N VAL A 690 SHEET 1 AA3 2 ILE A 798 LEU A 800 0 SHEET 2 AA3 2 THR A 806 ILE A 808 -1 O LYS A 807 N LEU A 799 SHEET 1 AA4 2 VAL A 824 LYS A 826 0 SHEET 2 AA4 2 ALA A 829 LEU A 831 -1 O LEU A 831 N VAL A 824 SHEET 1 AA5 5 LEU B 589 ALA B 597 0 SHEET 2 AA5 5 GLY B 601 ALA B 608 -1 O GLU B 605 N GLY B 592 SHEET 3 AA5 5 MET B 618 LEU B 625 -1 O MET B 618 N ALA B 608 SHEET 4 AA5 5 LEU B 667 GLU B 671 -1 O VAL B 668 N LYS B 623 SHEET 5 AA5 5 LEU B 656 CYS B 660 -1 N LEU B 657 O ILE B 669 SHEET 1 AA6 2 ILE B 798 LEU B 800 0 SHEET 2 AA6 2 THR B 806 ILE B 808 -1 O LYS B 807 N LEU B 799 SHEET 1 AA7 2 VAL B 824 LYS B 826 0 SHEET 2 AA7 2 ALA B 829 LEU B 831 -1 O LEU B 831 N VAL B 824 SITE 1 AC1 16 LEU A 595 VAL A 603 ALA A 621 LYS A 623 SITE 2 AC1 16 LEU A 644 THR A 670 GLU A 671 TYR A 672 SITE 3 AC1 16 CYS A 673 GLY A 676 LEU A 799 CYS A 809 SITE 4 AC1 16 ASP A 810 PHE A 811 HOH A1122 HOH A1148 SITE 1 AC2 17 LEU B 595 VAL B 603 ALA B 621 LYS B 623 SITE 2 AC2 17 GLU B 640 LEU B 644 THR B 670 GLU B 671 SITE 3 AC2 17 TYR B 672 CYS B 673 CYS B 674 LEU B 799 SITE 4 AC2 17 CYS B 809 ASP B 810 PHE B 811 HOH B1113 SITE 5 AC2 17 HOH B1118 CRYST1 88.190 91.650 92.030 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011339 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010911 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010866 0.00000